Search

Your search keyword '"Burger, Maximilian"' showing total 1,608 results
Start Over Author "Burger, Maximilian"
1,608 results on '"Burger, Maximilian"'

7. Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?

Author

Beijert, Irene J., Hentschel, Anouk E., Bründl, Johannes, Compérat, Eva M., Plass, Karin, Rodríguez, Oscar, Subiela Henríquez, Jose D., Hernández, Virginia, de la Peña, Enrique, Alemany, Isabel, Turturica, Diana, Pisano, Francesca, Soria, Francesco, Čapoun, Otakar, Bauerová, Lenka, Pešl, Michael, Bruins, H. Maxim, Runneboom, Willemien, Herdegen, Sonja, Breyer, Johannes, Brisuda, Antonin, Calatrava, Ana, Rubio-Briones, José, Seles, Maximilian, Mannweiler, Sebastian, Bosschieter, Judith, Kusuma, Venkata R. M., Ashabere, David, Huebner, Nicolai, Cotte, Juliette, Contieri, Roberto, Mertens, Laura S., Claps, Francesco, Masson-Lecomte, Alexandra, Liedberg, Fredrik, Cohen, Daniel, Lunelli, Luca, Cussenot, Olivier, El Sheikh, Soha, Volanis, Dimitrios, Côté, Jean-François, Rouprêt, Morgan, Haitel, Andrea, Shariat, Shahrokh F., Mostafid, A. Hugh, Nieuwenhuijzen, Jakko A., Zigeuner, Richard, Dominguez-Escrig, Jose L., Hacek, Jaromir, Zlotta, Alexandre R., Burger, Maximilian, Evert, Matthias, Hulsbergen-van de Kaa, Christina A., van der Heijden, Antoine G., Kiemeney, Lambertus A. L. M., Soukup, Viktor, Molinaro, Luca, Gontero, Paolo, Llorente, Carlos, Algaba, Ferran, Palou, Joan, N’Dow, James, Ribal, Maria J., van der Kwast, Theo H., Babjuk, Marko, Sylvester, Richard J., and van Rhijn, Bas W. G.

Published
2024
Full Text
View/download PDF

10. Simulation of the effects of molecular urine markers in follow-up of patients with high-risk non-muscle invasive bladder cancer

Author

Benderska-Söder, Natalya, Ecke, Thorsten, Kleinlein, Lisa, Roghmann, Florian, Bismarck, Ekkehardt, van Rhijn, Bas W.G., Stenzl, Arnulf, Witjes, Johannes Alfred, Todenhöfer, Tilman, Hakenberg, Oliver W., Grimm, Marc Oliver, Goebell, Peter J., Burger, Maximilian, Jensen, Jorgen Bjerggaard, and Schmitz-Dräger, Bernd J.

Published
2024
Full Text
View/download PDF

11. Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial)

Author

Breyer, Johannes, Eckstein, Markus, Sikic, Danijel, Wezel, Felix, Roghmann, Florian, Brehmer, Mirco, Wirtz, Ralph M., Jarczyk, Jonas, Erben, Philipp, Bahlinger, Veronika, Goldschmidt, Franziska, Fechner, Guido, Chen, Jack, Paxinos, Ellen, Bates, Michael, Haas, Maximilian, Zengerling, Friedemann, Bolenz, Christian, Burger, Maximilian, Hartmann, Arndt, and Kriegmair, Maximilian C.

Published
2023
Full Text
View/download PDF

14. Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty

Author

Bamias, Aristotelis, Stenzl, Arnulf, Brown, Stephanie L., Albiges, Laurence, Babjuk, Marko, Birtle, Alison, Briganti, Alberto, Burger, Maximilian, Choudhury, Ananya, Colecchia, Maurizio, De Santis, Maria, Fanti, Stefano, Fonteyne, Valérie, Gallucci, Michele, Rivas, Juan Gómez, Huddart, Robert, Junker, Kerstin, Kroeze, Stephanie, Loriot, Yohann, Merseburger, Axel, Montironi, Rodolfo, Necchi, Andrea, Oing, Christoph, Oldenburg, Jan, Ost, Piet, Pinkawa, Michael, Ribal, Maria J., Rouprêt, Morgan, Thoeny, Harriet, Zilli, Thomas, and Hoskin, Peter

Published
2023
Full Text
View/download PDF

17. International Opinions on Grading of Urothelial Carcinoma: A Survey Among European Association of Urology and International Society of Urological Pathology Members

Author

Beijert, Irene J., Cheng, Liang, Liedberg, Fredrik, Plass, Karin, Williamson, Sean R., Gontero, Paolo, Ribal, Maria J., Babjuk, Marko, Black, Peter C., Kamat, Ashish M., Algaba, Ferran, Berman, David M., Hartmann, Arndt, Masson-Lecomte, Alexandra, Rouprêt, Morgan, Lopez-Beltran, Antonio, Samaratunga, Hemamali, Shariat, Shahrokh F., Mostafid, A. Hugh, Varma, Murali, Shen, Steven, Burger, Maximilian, Tsuzuki, Toyonori, Palou, Joan, Compérat, Eva M., Sylvester, Richard J., van der Kwast, Theo H., van Rhijn, Bas W.G., and Downes, Michelle R.

Published
2023
Full Text
View/download PDF

18. Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non–muscle-invasive Spectrum

Author

Beijert, Irene J., Hentschel, Anouk E., Bründl, Johannes, Compérat, Eva M., Plass, Karin, Rodríguez, Oscar, Subiela Henríquez, Jose D., Hernández, Virginia, de la Peña, Enrique, Alemany, Isabel, Turturica, Diana, Pisano, Francesca, Soria, Francesco, Čapoun, Otakar, Bauerová, Lenka, Pešl, Michael, Bruins, H. Maxim, Runneboom, Willemien, Herdegen, Sonja, Breyer, Johannes, Brisuda, Antonin, Calatrava, Ana, Rubio-Briones, José, Seles, Maximilian, Mannweiler, Sebastian, Bosschieter, Judith, Kusuma, Venkata R.M., Ashabere, David, Huebner, Nicolai, Cotte, Juliette, Mertens, Laura S., Claps, Francesco, Masson-Lecomte, Alexandra, Liedberg, Fredrik, Cohen, Daniel, Lunelli, Luca, Cussenot, Olivier, El Sheikh, Soha, Volanis, Dimitrios, Côté, Jean-François, Rouprêt, Morgan, Haitel, Andrea, Shariat, Shahrokh F., Mostafid, A. Hugh, Nieuwenhuijzen, Jakko A., Zigeuner, Richard, Dominguez-Escrig, Jose L., Hacek, Jaromir, Zlotta, Alexandre R., Burger, Maximilian, Evert, Matthias, Hulsbergen-van de Kaa, Christina A., van der Heijden, Antoine G., Kiemeney, Lambertus A.L.M., Soukup, Viktor, Molinaro, Luca, Gontero, Paolo, Llorente, Carlos, Algaba, Ferran, Palou, Joan, N'Dow, James, Ribal, Maria J., van der Kwast, Theo H., Babjuk, Marko, Sylvester, Richard J., and van Rhijn, Bas.W.G.

Published
2023
Full Text
View/download PDF

22. Multi-Center Assessment of Lymph-Node Density and Nodal-Stage to Predict Disease-Specific Survival in Patients with Bladder Cancer Treated by Radical Cystectomy

Author

van Gennep, Erik J., primary, Claps, Francesco, additional, Bostrom, Peter J., additional, Shariat, Shahrokh F., additional, Neuzillet, Yann, additional, Zlotta, Alexandre R., additional, Trombetta, Carlo, additional, Eckstein, Markus, additional, Mertens, Laura S., additional, Bussani, Rossana, additional, Burger, Maximilian, additional, Boormans, Joost L., additional, Wullich, Bernd, additional, Hartmann, Arndt, additional, Mayr, Roman, additional, Pavan, Nicola, additional, Bartoletti, Riccardo, additional, Mir, M. Carmen, additional, Pouessel, Damien, additional, van der Hoeven, John, additional, van der Kwast, Theo H., additional, Allory, Yves, additional, Zuiverloon, Tahlita C.M., additional, Lotan, Yair, additional, and van Rhijn, Bas W.G., additional

Published
2024
Full Text
View/download PDF

23. Improving detection of carcinoma in situ in bladder cancer: urinary cytology vs the Xpert® BC Monitor

Author

Haas, Maximilian, primary, Kriegmair, Maximilian C., additional, Breyer, Johannes, additional, Sikic, Danijel, additional, Wezel, Felix, additional, Roghmann, Florian, additional, Brehmer, Mirco, additional, Wirtz, Ralph M., additional, Jarczyk, Jonas, additional, Erben, Philipp, additional, Bahlinger, Veronika, additional, Goldschmidt, Franziska, additional, Fechner, Guido, additional, Chen, Jack, additional, Paxinos, Ellen, additional, Bates, Michael, additional, Zengerling, Friedemann, additional, Bolenz, Christian, additional, Burger, Maximilian, additional, Hartmann, Arndt, additional, and Eckstein, Markus, additional

Published
2024
Full Text
View/download PDF

25. T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non–muscle-invasive Bladder Cancer Spectrum

Author

Beijert, Irene J., Hentschel, Anouk E., Bründl, Johannes, Compérat, Eva M., Plass, Karin, Rodríguez, Oscar, Subiela Henríquez, Jose D., Hernández, Virginia, de la Peña, Enrique, Alemany, Isabel, Turturica, Diana, Pisano, Francesca, Soria, Francesco, Čapoun, Otakar, Bauerová, Lenka, Pešl, Michael, Maxim Bruins, H., Runneboom, Willemien, Herdegen, Sonja, Breyer, Johannes, Brisuda, Antonin, Calatrava, Ana, Rubio-Briones, José, Seles, Maximilian, Mannweiler, Sebastian, Bosschieter, Judith, Kusuma, Venkata R.M., Ashabere, David, Huebner, Nicolai, Cotte, Juliette, Mertens, Laura S., Masson-Lecomte, Alexandra, Liedberg, Fredrik, Cohen, Daniel, Lunelli, Luca, Cussenot, Olivier, El Sheikh, Soha, Volanis, Dimitrios, Côté, Jean-François, Rouprêt, Morgan, Haitel, Andrea, Shariat, Shahrokh F., Mostafid, A. Hugh, Nieuwenhuijzen, Jakko A., Zigeuner, Richard, Dominguez-Escrig, Jose L., Hacek, Jaromir, Zlotta, Alexandre R., Burger, Maximilian, Evert, Matthias, Hulsbergen-van de Kaa, Christina A., van der Heijden, Antoine G., A.L.M. Kiemeney, Lambertus, Soukup, Viktor, Molinaro, Luca, Gontero, Paolo, Llorente, Carlos, Algaba, Ferran, Palou, Joan, N'Dow, James, Ribal, Maria J., van der Kwast, Theo H., Babjuk, Marko, Sylvester, Richard J., and van Rhijn, Bas.W.G.

Published
2022
Full Text
View/download PDF

27. Prognostic and Predictive Value of Fibroblast Growth Factor Receptor Alterations in High-grade Non–muscle-invasive Bladder Cancer Treated with and Without Bacillus Calmette-Guérin Immunotherapy

Author

Mayr, Roman, Eckstein, Markus, Wirtz, Ralph M., Santiago-Walker, Ademi, Baig, Mahadi, Sundaram, Ramesh, Carcione, Jenna Cody, Stoehr, Robert, Hartmann, Arndt, Bolenz, Christian, Burger, Maximilian, Otto, Wolfgang, Erben, Philipp, and Breyer, Johannes

Published
2022
Full Text
View/download PDF

29. Impact of COVID-19 crisis on medical care of patients with metastasized uro-oncologic disease under systemic cancer therapy: a multicenter study in German university hospitals

Author

Struck, Julian P., Schnoor, Maike, Schulze, Andrea, Hupe, Marie C., Ozimek, Tomasz, Oppolzer, Immanuel A., Schnabel, Marco J., Burger, Maximilian, Darr, Christopher, Gruenwald, Viktor, Hadaschik, Boris, Weinke, Maximilian, Kuebler, Hubert, Klockenbusch, Jonas C., Grabbert, Markus T., Gratzke, Christian, Kramer, Mario W., Katalinic, Alexander, and Merseburger, Axel S.

Published
2022
Full Text
View/download PDF

30. Expression of nectin-4 in papillary renal cell carcinoma

Author

Zschäbitz, Stefanie, Mikuteit, Marie, Stöhr, Christine, Herrmann, Edwin, Polifka, Iris, Agaimy, Abbas, Trojan, Lutz, Ströbel, Philipp, Becker, Frank, Wülfing, Christian, Barth, Peter, Stöckle, Michael, Staehler, Michael, Stief, Christian, Haferkamp, Axel, Hohenfellner, Markus, Duensing, Stefan, Macher-Göppinger, Stephan, Wullich, Bernd, Noldus, Joachim, Brenner, Walburgis, Roos, Frederik C., Walter, Bernhard, Otto, Wolfgang, Burger, Maximilian, Schrader, Andres Jan, Hartmann, Arndt, Erlmeier, Franziska, and Steffens, Sandra

Published
2022
Full Text
View/download PDF

33. A novel grading approach predicts worse outcomes in stage pT1 non‐muscle‐invasive bladder cancer.

Author

Haas, Maximilian, Engelmann, Simon U., Mayr, Roman, Gossler, Christopher, Pickl, Christoph, Kälble, Sebastian, Yang, Yushan, Otto, Wolfgang, Hartmann, Valerie, Burger, Maximilian, Hartmann, Arndt, Breyer, Johannes, and Eckstein, Markus

Subjects
BLADDER cancer, NON-muscle invasive bladder cancer, TRANSURETHRAL resection of bladder, BLADDER obstruction, CANCER patients, PROGNOSIS, OVERALL survival, UROTHELIUM
Abstract

Objective: To develop a prognostically relevant scoring system for stage pT1 non‐muscle‐invasive bladder cancer (NMIBC) incorporating tumour budding, growth pattern and invasion pattern because the World Health Organisation grading system shows limited prognostic value in such patients. Patients and Methods: The tissue specimens and clinical data of 113 patients with stage pT1 NMIBC who underwent transurethral resection of bladder tumour were retrospectively investigated. Tumour budding, and growth and invasion patterns were evaluated and categorised into two grade groups (GGs). GGs and other clinical and histopathological variables were investigated regarding recurrence‐free survival (RFS), progression‐free survival (PFS), cancer‐specific survival (CSS) and overall survival (OS) using univariable and multivariable Cox regression analyses. Results: The integration of two tumour budding groups, two growth patterns, and two invasion patterns yielded an unfavourable GG (n = 28; 24.7%) that had a high impact on oncological outcomes. The unfavourable GG was identified as an independent RFS and OS predictor (P = 0.004 and P = 0.046, respectively) and linked to worse PFS (P = 0.001) and CSS (P = 0.001), irrespective of the European Association of Urology risk group. The unfavourable GG was associated with higher rates of BCG‐unresponsive tumours (P = 0.006). Study limitations include the retrospective, single‐centre design, diverse therapies and small cohort. Conclusions: We present a morphology‐based grading system for stage pT1 NMIBC that correlates with disease aggressiveness and oncological patient outcomes. It therefore identifies a highest risk group of stage pT1 NMIBC patients, who should be followed up more intensively or receive immediate radical cystectomy. The grading incorporates objective variables assessable on haematoxylin and eosin slides and immunohistochemistry, enabling an easy‐to‐use low‐cost approach that is applicable in daily routine. Further studies are needed to validate and confirm these results. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

34. Risk factors associated with positive surgical margins’ location at radical cystectomy and their impact on bladder cancer survival

Author

Claps, Francesco, van de Kamp, Maaike W., Mayr, Roman, Bostrom, Peter J., Boormans, Joost L., Eckstein, Markus, Mertens, Laura S., Boevé, Egbert R., Neuzillet, Yann, Burger, Maximilian, Pouessel, Damien, Trombetta, Carlo, Wullich, Bernd, van der Kwast, Theo H., Hartmann, Arndt, Allory, Yves, Lotan, Yair, Shariat, Shahrokh F., Zuiverloon, Tahlita C. M., Mir, M. Carmen, and van Rhijn, Bas W. G.

Published
2021
Full Text
View/download PDF

43. Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non–muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non–muscle-invasive Bladder Cancer Guidelines Panel Study

Author

van Rhijn, Bas W.G., Hentschel, Anouk E., Bründl, Johannes, Compérat, Eva M., Plass, Karin, Rodríguez, Oscar, Subiela Henríquez, Jose D., Hernández, Virginia, de la Peña, Enrique, Alemany, Isabel, Turturica, Diana, Pisano, Francesca, Soria, Francesco, Čapoun, Otakar, Bauerová, Lenka, Pešl, Michael, Bruins, H. Maxim, Runneboom, Willemien, Herdegen, Sonja, Breyer, Johannes, Brisuda, Antonin, Calatrava, Ana, Rubio-Briones, José, Seles, Maximilian, Mannweiler, Sebastian, Bosschieter, Judith, Kusuma, Venkata R.M., Ashabere, David, Huebner, Nicolai, Cotte, Juliette, Mertens, Laura S., Cohen, Daniel, Lunelli, Luca, Cussenot, Olivier, El Sheikh, Soha, Volanis, Dimitrios, Côté, Jean-François, Rouprêt, Morgan, Haitel, Andrea, Shariat, Shahrokh F., Mostafid, A. Hugh, Nieuwenhuijzen, Jakko A., Zigeuner, Richard, Dominguez-Escrig, Jose L., Hacek, Jaromir, Zlotta, Alexandre R., Burger, Maximilian, Evert, Matthias, Hulsbergen - van de Kaa, Christina A., van der Heijden, Antoine G., Kiemeney, Lambertus A.L.M., Soukup, Viktor, Molinaro, Luca, Gontero, Paolo, Llorente, Carlos, Algaba, Ferran, Palou, Joan, N’Dow, James, van der Kwast, Theo H., Babjuk, Marko, and Sylvester, Richard J.

Published
2021
Full Text
View/download PDF

44. Characterization of PD-1 and PD-L1 Expression in Papillary Renal Cell Carcinoma: Results of a Large Multicenter Study

Author

Erlmeier, Franziska, Steffens, Sandra, Stöhr, Christine, Herrmann, Edwin, Polifka, Iris, Agaimy, Abbas, Trojan, Lutz, Ströbel, Philipp, Becker, Frank, Wülfing, Christian, Barth, Peter, Stöckle, Michael, Staehler, Michael, Stief, Christian, Haferkamp, Axel, Hohenfellner, Markus, Macher-Göppinger, Stephan, Wullich, Bernd, Noldus, Joachim, Brenner, Walburgis, Roos, Frederik C., Walter, Bernhard, Otto, Wolfgang, Burger, Maximilian, Schrader, Andres Jan, Hartmann, Arndt, and Ivanyi, Philipp

Published
2021
Full Text
View/download PDF

46. Long-Term Follow-Up of Peritoneal Interposition Flap in Symptomatic Lymphocele Reduction following Robot-Assisted Radical Prostatectomy: Insights from the PIANOFORTE Trial.

Author

Goßler, Christopher, May, Matthias, Weikert, Steffen, Lenart, Sebastian, Ponholzer, Anton, Dreissig, Christina, Stojanoski, Gjoko, Anzinger, Isabel, Riester, Josef, Burger, Maximilian, Gilfrich, Christian, Mayr, Roman, and Bründl, Johannes

Subjects
SURGICAL robots, CANCER relapse, RADICAL prostatectomy, LYMPHOCELE, MANN Whitney U Test, DESCRIPTIVE statistics, SURGICAL complications, LONGITUDINAL method, DATA analysis software, PATIENT aftercare
Abstract

Simple Summary: Lymphoceles (lymphatic fluid collections in the pelvis) are a common complication of robot-assisted radical prostatectomy. Peritoneal interposition flaps have been proposed as an intraoperative modification to reduce lymphocele formation. However, data from randomised controlled trials on this subject are not conclusive. In particular, data on long-term efficacy and complications are lacking. The PIANOFORTE trial was the first randomised controlled trial exploring this subject and showed a negative outcome regarding lymphocele reduction by performing a peritoneal interposition flap. In this long-term follow-up of the trial (median 43 months postoperatively), we could confirm the initial result that, while the interposition flap does not have a negative impact on complications or functionality, there is also no effect on lymphocele reduction in the long term. Additionally, these results confirm the possibility of lymphocele formation beyond the third postoperative month, which has to be borne in mind in the follow-up of these patients. The available randomised controlled trials (RCTs) assessing the influence of peritoneal interposition flaps (PIF) on the reduction of symptomatic lymphoceles (sLCs) post robot-assisted radical prostatectomy (RARP) do not constitute a sufficient follow-up (FU) to assess the long-term effects. The PIANOFORTE trial was the first of these RCTs, showing no sLC reduction at the 3-month FU. Therefore, all 232 patients from the PIANOFORTE trial were invited for long-term FU. One hundred seventy-six patients (76%) presented themselves for FU and constituted the study group (SG). The median FU duration was 43 months. No significant differences in group allocation or LC endpoints at 90 days were observed between SG patients and patients not presenting themselves for the FU. During the FU period, four patients (2.3%) in the SG developed sLCs, and six patients (3.4%) developed asymptomatic lymphoceles (aLCs), which persisted in five patients (2.9%). There were no significant differences between PIF and non-PIF regarding sLC/aLC formation or persistence, newly developed complications, stress urinary incontinence or biochemical/clinical tumour recurrence. Therefore, this long-term FU confirms the primary outcomes of the PIANOFORTE trial that, while PIF does not impact complications or functionality, it does not reduce sLC/aLC rates. Furthermore, it shows the potential occurrence of LC after the third postoperative month. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

47. Evaluating the Efficacy of AI Chatbots as Tutors in Urology: A Comparative Analysis of Responses to the 2022 In-Service Assessment of the European Board of Urology.

Author

May, Matthias, Körner-Riffard, Katharina, Kollitsch, Lisa, Burger, Maximilian, Brookman-May, Sabine D., Rauchenwald, Michael, Marszalek, Martin, and Eredics, Klaus

Subjects
ARTIFICIAL intelligence, LANGUAGE models, CHATGPT, CHATBOTS, ERROR rates
Abstract

Introduction: This study assessed the potential of large language models (LLMs) as educational tools by evaluating their accuracy in answering questions across urological subtopics. Methods: Three LLMs (ChatGPT-3.5, ChatGPT-4, and Bing AI) were examined in two testing rounds, separated by 48 h, using 100 Multiple-Choice Questions (MCQs) from the 2022 European Board of Urology (EBU) In-Service Assessment (ISA), covering five different subtopics. The correct answer was defined as "formal accuracy" (FA) representing the designated single best answer (SBA) among four options. Alternative answers selected from LLMs, which may not necessarily be the SBA but are still deemed correct, were labeled as "extended accuracy" (EA). Their capacity to enhance the overall accuracy rate when combined with FA was examined. Results: In two rounds of testing, the FA scores were achieved as follows: ChatGPT-3.5: 58% and 62%, ChatGPT-4: 63% and 77%, and BING AI: 81% and 73%. The incorporation of EA did not yield a significant enhancement in overall performance. The achieved gains for ChatGPT-3.5, ChatGPT-4, and BING AI were as a result 7% and 5%, 5% and 2%, and 3% and 1%, respectively (p > 0.3). Within urological subtopics, LLMs showcased best performance in Pediatrics/Congenital and comparatively less effectiveness in Functional/BPS/Incontinence. Conclusion: LLMs exhibit suboptimal urology knowledge and unsatisfactory proficiency for educational purposes. The overall accuracy did not significantly improve when combining EA to FA. The error rates remained high ranging from 16 to 35%. Proficiency levels vary substantially across subtopics. Further development of medicine-specific LLMs is required before integration into urological training programs. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

48. Risk Stratification Tools and Prognostic Models in Non–muscle-invasive Bladder Cancer: A Critical Assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel

Author

Soukup, Viktor, Čapoun, Otakar, Cohen, Daniel, Hernández, Virginia, Burger, Maximilian, Compérat, Eva, Gontero, Paolo, Lam, Thomas, Mostafid, A. Hugh, Palou, Joan, van Rhijn, Bas W.G., Rouprêt, Morgan, Shariat, Shahrokh F., Sylvester, Richard, Yuan, Yuhong, Zigeuner, Richard, and Babjuk, Marek

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results